Abstract Ulcerative colitis (UC) represents a chronic, relapsing inflammatory condition primarily affecting the colonic and rectal mucosa, presenting substantial challenges to healthcare systems globally
Britain appears to be on a similar trajectory, where 5% of adults, or nearly 3 million people, are now on the drugs while 9% have taken one at some point, says new research from the consultancy PwC
Before treatment, a clinician may review weight history, medical conditions, medication use, diabetes treatment, gastrointestinal history, thyroid cancer history, pregnancy plans, previous weight-loss attempts, and goals
I think it just depends on your preferences
Storage conditions are governed by the trial sponsor's Pharmacy Manual, the IMP label, and UK Good Clinical Practice not a public SmPC
Starting January 1, 2026 , several major insurance providers, including Blue Cross Blue Shield (BCBS), Cigna, Harvard Pilgrim, and UnitedHealthcare, will implement changes to their coverage of GLP-1 medications